Genus (GNS.L) Stock Price
£2610 0.4%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Genus, AI stock picks, stock alerts and much more.
GNS.L AI Stock Analysis
AI stock analysis for GNS.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Genus (GNS.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Genus (GNS.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Genus (GNS.L), currently trading at £2610, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GNS.L
-
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
-
Symbol
GNS.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
1.7B
Similar Stocks
 |
Codexis 0I0X.L |
$3.01 0.7% |
5 |
 |
Oxford Nanopore Technologies plc ONT.L |
£209.8 0.3% |
7 |
 |
Sareum Holdings SAR.L |
£23 18% |
5 |
 |
Viridian Therapeutics 0K1R.L |
$18.57 5% |
6 |
 |
Avacta Group Plc AVCT.L |
£50.7 5.6% |
4 |
News
GNS.L Alternative Data
Web Traffic
Genus receives an estimated 80631 monthly visitors to genusplc.com.
-
Web Traffic
80631
-
Change from Previous Month
14.6%
-
3 Month Change
47.3%
-
YoY Change
47.3%
Twitter Followers
Genus has 5,884 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
5884
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.3%
Facebook Engagement
Genus has engaged 346 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
346
-
Daily Change
9.1%
-
1 Month Change
152.6%
-
3 Month Change
565.4%
Youtube Subscribers
Genus has 28 subscribers on its main Youtube channel.
-
Youtube Subscribers
28
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Genus has an estimated 64 open job postings, which is down -5.9% over the last month.
-
Job Postings
64
-
Daily Change
0%
-
1 Month Change
5.9%
-
3 Month Change
28%
Reddit Mentions
Genus has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Genus has 7,741 Instagram Followers on its main Instagram account, up by 1% over the last month.
-
Instagram Followers
7741
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
1.9%
LinkedIn Followers
19,468 are following Genus on LinkedIn, up by 2.8% over the last month.
-
LinkedIn Followers
19468
-
Daily Change
2.8%
-
1 Month Change
2.8%
-
3 Month Change
7.8%
LinkedIn Employees
According to LinkedIn, Genus has 1,440 employees, up by 0.5% over the last month.
-
LinkedIn Employees
1440
-
Daily Change
0.5%
-
1 Month Change
0.5%
-
3 Month Change
2.6%
Business Outlook
According to employee reviews, the business outlook among employees at Genus is 45 out of 100 (neutral).
-
Business Outlook
45
-
Change from Previous Month
0%
-
3 Month Change
11.8%
-
YoY Change
11.8%
News Mentions
Genus was mentioned 14 times in the news yesterday.
-
News Mentions
14
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
GNS.L Financials
GNS.L Key Metrics
-
Total Revenue
£336.4M
-
Net Income
£1.6M
-
Earnings per Share
£0.0243
-
Free cash flow
£20.3M
-
EBITDA
£31.4M
-
EBITDA Ratio
0.0933413
-
Total Assets
£985.9M
GNS.L 2-year Revenue & Income
GNS.L 2-year Free Cash Flow
GNS.L Technicals
GNS.L SMA
GNS.L RSI
FAQ
What's the current price of Genus (GNS.L) Stock?
The price of an Genus (GNS.L) share is £2610.
What's the market cap of Genus?
The current market cap of Genus is 1.7B.
Should I buy or sell GNS.L?
Genus shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Genus is better viewed as a hold or accumulate position while waiting for further developments.
Is Genus a good investment?
The current analysis of Genus' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Genus' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Genus (GNS.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Genus stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Genus (GNS.L) that investors often compare it to?
Genus (GNS.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Genus' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Genus' stock price to be around £2740.2 in 2026. Starting from the current price of £2610, this represents a 5% change in price, indicating a neutral outlook for the stock.
How to buy Genus (GNS.L) Stock?
Genus stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Genus shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.